|
|
|
|
| LEADER |
03184nam a22004815i 4500 |
| 001 |
978-1-61779-615-9 |
| 003 |
DE-He213 |
| 005 |
20151125201706.0 |
| 007 |
cr nn 008mamaa |
| 008 |
120403s2012 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781617796159
|9 978-1-61779-615-9
|
| 024 |
7 |
|
|a 10.1007/978-1-61779-615-9
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RB1-214
|
| 072 |
|
7 |
|a MMF
|2 bicssc
|
| 072 |
|
7 |
|a MED067000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.07
|2 23
|
| 245 |
1 |
0 |
|a Biotargets of Cancer in Current Clinical Practice
|h [electronic resource] /
|c edited by Mauro Bologna.
|
| 264 |
|
1 |
|a Totowa, NJ :
|b Humana Press,
|c 2012.
|
| 300 |
|
|
|a XVI, 563 p. 100 illus., 57 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Current Clinical Pathology
|
| 505 |
0 |
|
|a Central Nervous System Tumors -- Head and Neck Tumors -- Thyroid Cancer -- Targeted Therapies for Non-Small Cell Lung Cancer -- Non-Hodgkin Lymphomas -- Leukemias -- Breast Cancer -- Esophago-Gastric Cancer -- Colorectal Cancer -- Hepatocellular Carcinoma -- Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma -- Bladder Cancer -- Biomarkers in Prostate cancer -- Ovarian Cancer -- Uterine Cancer: The Influence of Genetics and Environment on Cell Cycling Pathways in Cancer -- Biotargets in Sarcomas: The Past, Present and a Look into the Future -- Melanoma and other skin cancers -- Molecular pathology of cancer metastasis: suggestions for future therapy -- Current and future developments in cancer therapy research: miRNAs as new promising targets or tools.
|
| 520 |
|
|
|a Biotargets of Cancer in Current Clinical Practice presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, a comprehensive although concise discussion of epidemiology, affirmed and innovative biomarkers for diagnosis, and descriptions of the relevant genes for prognosis and (individualized) therapy through biotarget-specific new molecular treatments, with the latest information on the validation status of each novel biomarker. Individual chapters are dedicated to the major cancer types, plus a special chapter on metastasis. The present debate on patentability of genetic information applied to diagnostics and therapeutics of cancer is also discussed.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Laboratory medicine.
|
| 650 |
|
0 |
|a Oncology.
|
| 650 |
|
0 |
|a Pathology.
|
| 650 |
1 |
4 |
|a Medicine & Public Health.
|
| 650 |
2 |
4 |
|a Pathology.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 650 |
2 |
4 |
|a Laboratory Medicine.
|
| 700 |
1 |
|
|a Bologna, Mauro.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9781617796142
|
| 830 |
|
0 |
|a Current Clinical Pathology
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-1-61779-615-9
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SME
|
| 950 |
|
|
|a Medicine (Springer-11650)
|
